Tenofovir disoproxil fumarate significantly decreases serum lipoprotein levels compared with entecavir nucleos(t)ide analogue therapy in chronic hepatitis B carriers - Concepedia

Concepedia

Publication | Open Access

Tenofovir disoproxil fumarate significantly decreases serum lipoprotein levels compared with entecavir nucleos(t)ide analogue therapy in chronic hepatitis B carriers

DOI Full Paper Access

57

Citations

13

References

2017

Year

Abdel Aziz Shaheen, Maen Almattooq, S. Yazdanfar, Kelly W. Burak, Mark G. Swain, Stephen E. Congly, Meredith A. Borman, Shoei‐Sheng Lee, Robert P. Myers, Carla S. Coffin

Alimentary Pharmacology & Therapeutics

Abstract

A greater decline in TC, LDL-C and HDL was observed in CHB carriers receiving TDF compared with ETV. These data may influence anti-viral choice in CHB carriers at risk for CVD.

References

	Year	Citations

Page 1